论文部分内容阅读
目的:从临床罕见病例入手重新认识卵巢癌的特殊转移途径从而丰富卵巢癌胃转移的临床知识,为卵巢癌胃转移的诊治提供更多临床参考。方法:通过对起病特点、诊疗经过、疗效及预后等方面做一详细报道并结合文献复习对其加以分析讨论,以期对卵巢癌胃转移这一特殊转移途径获得更深刻的认识以指导临床。结果:分析发现卵巢癌发生胃转移时胃肠道症状不明显,多是于跟踪复查过程中发现,其治疗上以肿瘤减瘤术为主,疗效较为明确,后期多以紫杉类联合铂类药物进行化疗,但该病易复发,预后多较差。结论:卵巢癌胃转移临床罕发,临床易于漏诊,宜密切随访,对病情进行动态评估。治疗方面经发现后以手术切除联合后期以抗微管蛋白合成的药物及铂类制剂为主。。
OBJECTIVE: To start from the rare clinical cases to re-recognize the special metastatic pathway of ovarian cancer so as to enrich the clinical knowledge of gastric metastasis of ovarian cancer and provide more clinical reference for the diagnosis and treatment of gastric metastasis of ovarian cancer. Methods: To make a detailed report on the characteristics of onset, diagnosis and treatment, curative effect and prognosis, combined with the review of the literature to analyze and discuss it, with a view to gain a deeper understanding of the special metastatic pathway of gastric metastasis of ovarian cancer to guide clinical. Results: The analysis found that gastrointestinal symptoms of gastric cancer metastasis is not obvious, mostly in the follow-up process found that the treatment of tumor-based tumor reduction, the effect is more clear, the latter part of more taxane combined with platinum Drugs for chemotherapy, but the disease is easy to relapse, the prognosis is more poor. Conclusions: The patients with gastric metastasis of ovarian cancer are seldom clinically diagnosed, and the clinical diagnosis is easy to be missed. The follow-up should be followed closely and the condition should be evaluated dynamically. Treatment was found after the surgical resection combined anti-tubulin synthesis of drugs and platinum-based preparations. .